Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Appointed director
CC transcript
Inv. presentation
Acq. announced

NeurogesX Inc (NGSX) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/13/2017 SC 13G/A Henriques Charles A. reports a 15% stake in NeurogesX, Inc.
02/09/2017 SC 13G/A KCG AMERICAS LLC reports a 5.1% stake in NeurogesX, Inc.    
02/17/2016 SC 13G/A Henriques Charles A. reports a 13.8% stake in NeurogesX, Inc.
07/11/2013 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disp...
06/24/2013 8-K Quarterly results
04/17/2013 8-K Acquisition/merger/asset purchase announced
03/27/2013 8-K SEC Filing in the EDGAR database
03/27/2013 EFFECT Form EFFECT - Notice of Effectiveness
03/27/2013 EFFECT Form EFFECT - Notice of Effectiveness
03/27/2013 EFFECT Form EFFECT - Notice of Effectiveness
03/27/2013 EFFECT Form EFFECT - Notice of Effectiveness
03/25/2013 POS AM Form POS AM - Post-Effective amendments for registration statement
03/25/2013 POS AM Form POS AM - Post-Effective amendments for registration statement
03/25/2013 POS AM Form POS AM - Post-Effective amendments for registration statement
03/25/2013 POS AM Form POS AM - Post-Effective amendments for registration statement
03/11/2013 8-K Entry into a Material Definitive Agreement, Other Events
03/05/2013 8-K Cost Associated with Exit or Disposal Activities, Other Events
01/08/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/03/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
12/04/2012 4 Ghiglieri Stephen F (Exec. V.P., COO & CFO) has filed a Form 4 on NeurogesX Inc
11/30/2012 8-K Cost Associated with Exit or Disposal Activities, Other Events
11/14/2012 10-Q Quarterly Report for the period ended September 30, 2012
11/14/2012 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
09/19/2012 4/A Markels Michael (Senior VP,Commercial & Bus Dev) has filed a Form 4 on NeurogesX Inc
09/14/2012 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
09/14/2012 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
09/05/2012 4 Markels Michael (Senior VP,Commercial & Bus Dev) has filed a Form 4 on NeurogesX Inc
09/05/2012 4 Ghiglieri Stephen F (Exec. V.P., COO & CFO) has filed a Form 4 on NeurogesX Inc
08/30/2012 GN NeurogesX' NGX-1998 Well-Tolerated Treatment Demonstrated Clear Dose-Response in Patients
08/24/2012 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
08/10/2012 10-Q Quarterly Report for the period ended June 30, 2012
08/07/2012 4 Markels Michael (Senior VP,Commercial & Bus Dev) has filed a Form 4 on NeurogesX Inc
08/07/2012 4 Ghiglieri Stephen F (Exec. V.P., COO & CFO) has filed a Form 4 on NeurogesX Inc
08/07/2012 8-K Other Events, Financial Statements and Exhibits
Docs: "NeurogesX Provides Regulatory Update For NGX-1998 Clinical Program End-of Phase 2 FDA Guidance Supports Plan To Enter Phase 3 Development Later This Year San Mateo, Calif., - NeurogesX, Inc. , a specialty pharmaceutical company focused on developing and commercializing a portfolio of novel non-opioid, pain management therapies, today provided an update on its regulatory process for NGX-1998, the Company's next generation liquid formulation of prescription-strength capsaicin. NeurogesX recently received End-of-Phase 2 guidance from the U.S. Food and Drug Administration regarding its previously announced plans for the Phase 3 clinical development of NGX-1998 as a treatment for neuropathic pain conditions, including key elements of its overall development plan related to manufacturing, applic..."
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy